Series – Page 4 – Talk Bio

Actionable Insights Powered by AI

Myricx Bio Secures £90m ($114m) Series A Financing to Advance Novel NMTi ADC Therapeutics

1 year ago talkbio0Tagged Bio, Eli Lilly, financing characteristics, Holdings, Malignant Neoplasms, Myricx, NMTi, Series, therapeutic autologous dendritic cells

Myricx Bio, Series A Financing, NMTi ADC Therapeutics, Novo Holdings, Lilly, Cancer Treatment

Myricx Secures $114M Funding with Lilly’s Support for ADC Development

1 year ago talkbio0Tagged ADCs, biotech, Eli, Eli Lilly, Myricx, Series

Myricx, Eli Lilly, ADCs, Biotech Funding, Series A

Curie.Bio Raises $380M to Support Early-Stage Biotechs

1 year ago talkbio0Tagged accelerator, Bio, biotechs, Borisy, Curie, Early-stage, Series, venture, Weinberg, Zach

Curie.Bio, biotech accelerator, venture capital, Series A rounds, early-stage biotechs, Alexis Borisy, Zach Weinberg

Novo Holdings Supports Reunion Neuroscience’s $103M Series A Funding for Pioneering Psychedelic Clinical Trials

2 years ago talkbio0Tagged Biotechnology, Funding, Health care facility, Holdings, Investments, mental health, mental health innovation, Neuroscience discipline, psychedelic clinical trials, Reunion Island, Series, venture

Novo Holdings, Reunion Neuroscience, Series A funding, psychedelic clinical trials, mental health treatments, mental health innovation, venture capital, biotechnology, healthcare investments.